Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease

Gut

Volumn 40, Issue 5, 1997, Pages 619-622

  Evans, J M M ^a   McMahon, A D ^a   Murray, F E ^a   McDevitt, D G ^a   MacDonald, T M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Case control study; Colitis; Crohn's colitis; NSAIDs; Ulcerative colitis

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; COLITIS; CONTROLLED STUDY; EMERGENCY; ENTERITIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030913612     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.5.619     Document Type: Article

References (17)

1. Garcia-Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72.
2. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8.
3. Phillips MS, Fehilly B, Stewart S, Dronfield MW. Enteritis and colitis associated with mefenamic acid. BMJ 1987; 287: 1626.
4. Hall RI, Petty AH, Cobden I, Lendrum R. Enteritis and colitis associated with mefenamic acid. BMJ 1983; 287: 1182.
5. Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 1987; 107: 513-6.
6. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by non-steroidal anti-inflammatory drugs. Arch Intern Med 1992; 152: 625-32.
7. Gleeson M, Ramsay D, Hutchinson S, Spencer D, Monteith G. Colitis associated with non-steroidal anti-inflammatory drugs. Lancet 1994; 344: 1028.
8. International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. Vol 1. Geneva: World Health Organisation, 1977.
9. Evans JMM, McDevitt DG, MacDonald TM. The Tayside Medicines Monitoring Unit: a record-linkage system for pharmacovigilance. Pharmaceutical Medicine 1995; 9: 165-76.
10. MacDonald TM, McDevitt DG. The Tayside Medicines Monitoring Unit (MEMO). In: Strom BL, ed. Pharmacoepidemiology, 2nd edn. Chichester: Wiley, 1994: 245-55.
11. Evans JMM, McMahon AD, McGilchrist MM, White G, McDevitt DG, MacDonald TM. Topical non-steroidal anti-inflammatory drugs and hospitalisation for upper gastrointestinal bleeding and perforation. BMJ 1995; 311: 22-6.
12. Evans JMM, McGregor E, McMahon AD, McGilchrist MM, Jones MC, White G, et al. Non-steroidal anti-inflammatory drugs and hospitalisation for acute renal failure. Q J Med 1995; 88: 551-7.
13. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 24: 2-6.
14. Walt RP, Hawkey CJ, Langman MJS. Colitis associated with non-steroidal anti-inflammatory drugs. BMJ 1984; 288: 218.
15. Mills JL. Data torturing. N Engl J Med 1993; 329: 1196-9.
16. Lichtman SN, Sartor RB. Extraintestinal manifestations of inflammatory bowel disease: clinical aspects and natural history. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease. From bench to bedside. Baltimore: Williams and Wilkins, 1994: 317-35.
17. Lasky T, Stolley PD. Selection of cases and controls. Epidemiol Rev 1994; 16: 6-17.